Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 Diabetes

Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 Diabetes

The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose monitoring in pregnant women with type 1 diabetes. We analyzed CGM and glycated hemoglobin (HbA ) measures in first (  = 221), second (  = 197), and third (  = 172) trimesters, aiming to examine target...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes technology & therapeutics 2021-10, Vol.23 (10), p.710-714
Hauptverfasser: Tundidor, Diana, Meek, Claire L, Yamamoto, Jennifer, Martínez-Bru, Cecilia, Gich, Ignasi, Feig, Denice S, Murphy, Helen R, Corcoy, Rosa
Format: Artikel
Sprache:eng
Schlagworte:
Blood Glucose
Blood Glucose Self-Monitoring
Diabetes Mellitus, Type 1 - drug therapy
Female
Glycated Hemoglobin A - analysis
Humans
Infant, Newborn
Pregnancy
Pregnancy Outcome
Pregnant Women
Premature Birth
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose monitoring in pregnant women with type 1 diabetes. We analyzed CGM and glycated hemoglobin (HbA ) measures in first (  = 221), second (  = 197), and third (  = 172) trimesters, aiming to examine target glucose attainment and associations with pregnancy outcomes. CGM targets were Time-in-range (TIR) > 70%, Time-above-range (TAR)
ISSN:1520-9156
1557-8593
DOI:10.1089/dia.2021.0073